Efrotomycin

Star0

DB11401ExperimentalVet approvedSmall molecule

Efrotomycin: Overview.

Formula / weight: C₅₉H₈₈N₂O₂₀ · 1145.347 g/mol (avg)

Resolves to

Compound

UNII5BPJ82Q45X

Structure

InChIKeyZLECMEJICSWJLT-LIWMBINXSA-NSMILES

[H]\C(C)=C(\[H])/C(/[H])=C(\[H])C1OC(O)(C(CC)C(O)=NC\C([H])=C(/[H])\C(\[H])=C(/C)C(OC)C(C)C2OC(\C([H])=C(/[H])\C(\[H])=C(/[H])C([H])=C(C)C(\O)=C3\C(=O)C=CN(C)C3=O)C(O)C2O)C(O)C(OC2OC(C)C(OC3OC(C)C(OC)C(O)C3OC)C(OC)C2O)C1(C)C

What you can answer from here — as of March 06, 2025

56Drug interactionsStructured to mechanism, not free text

10+ReferencesStructured and connected to the statements they support

Which companies are running trials of Efrotomycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account